• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体在肝细胞癌中的作用及中医药调控

Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine.

作者信息

Yao Man, Liang Shufang, Cheng Binbin

机构信息

Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University (The Second Military Medical University), Shanghai, China.

Faculty of Traditional Chinese Medicine, Naval Medical University (The Second Military Medical University), Shanghai, China.

出版信息

Front Pharmacol. 2023 Jan 17;14:1110922. doi: 10.3389/fphar.2023.1110922. eCollection 2023.

DOI:10.3389/fphar.2023.1110922
PMID:36733504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9886889/
Abstract

Hepatocellular carcinoma (HCC) usually occurs on the basis of chronic liver inflammatory diseases and cirrhosis. The liver microenvironment plays a vital role in the tumor initiation and progression. Exosomes, which are nanometer-sized membrane vesicles are secreted by a number of cell types. Exosomes carry multiple proteins, DNAs and various forms of RNA, and are mediators of cell-cell communication and regulate the tumor microenvironment. In the recent decade, many studies have demonstrated that exosomes are involved in the communication between HCC cells and the stromal cells, including endothelial cells, macrophages, hepatic stellate cells and the immune cells, and serve as a regulator in the tumor proliferation and metastasis, immune evasion and immunotherapy. In addition, exosomes can also be used for the diagnosis and treatment HCC. They can potentially serve as specific biomarkers for early diagnosis and drug delivery vehicles of HCC. Chinese herbal medicine, which is widely used in the prevention and treatment of HCC in China, may regulate the release of exosomes and exosomes-mediated intercellular communication. In this review, we summarized the latest progresses on the role of the exosomes in the initiation, progression and treatment of HCC and the potential value of Traditional Chinese medicine in exosomes-mediated biological behaviors of HCC.

摘要

肝细胞癌(HCC)通常发生在慢性肝脏炎症性疾病和肝硬化的基础上。肝脏微环境在肿瘤的发生和进展中起着至关重要的作用。外泌体是由多种细胞类型分泌的纳米级膜泡。外泌体携带多种蛋白质、DNA和各种形式的RNA,是细胞间通讯的介质,并调节肿瘤微环境。在最近十年中,许多研究表明外泌体参与了HCC细胞与基质细胞之间的通讯,包括内皮细胞、巨噬细胞、肝星状细胞和免疫细胞,并在肿瘤增殖和转移、免疫逃逸及免疫治疗中发挥调节作用。此外,外泌体还可用于HCC的诊断和治疗。它们有可能作为HCC早期诊断的特异性生物标志物和药物递送载体。在中国广泛用于预防和治疗HCC的中药,可能会调节外泌体的释放以及外泌体介导的细胞间通讯。在本综述中,我们总结了外泌体在HCC发生、进展和治疗中的作用以及中药在外泌体介导的HCC生物学行为中的潜在价值的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/523a/9886889/029431034d96/fphar-14-1110922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/523a/9886889/029431034d96/fphar-14-1110922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/523a/9886889/029431034d96/fphar-14-1110922-g001.jpg

相似文献

1
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine.外泌体在肝细胞癌中的作用及中医药调控
Front Pharmacol. 2023 Jan 17;14:1110922. doi: 10.3389/fphar.2023.1110922. eCollection 2023.
2
Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).外泌体及其微小 RNA 在肝细胞癌中的作用:在诊断和抗肿瘤治疗中的潜力(综述)。
Int J Mol Med. 2018 Apr;41(4):1809-1816. doi: 10.3892/ijmm.2018.3383. Epub 2018 Jan 11.
3
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation.揭示肝癌中 M1 和 M2 巨噬细胞的阴阳平衡:外泌体在肿瘤微环境和免疫调节中的作用。
Cells. 2023 Aug 10;12(16):2036. doi: 10.3390/cells12162036.
4
[Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].[肝癌衍生的外泌体:肿瘤微环境中细胞间通讯的关键参与者]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 20;55(1):6-12. doi: 10.12182/20240160203.
5
Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.改良艾痛消方(I-ATXP)诱导肝癌(HCC)细胞凋亡、细胞周期阻滞并阻断外泌体释放。
Int J Physiol Pathophysiol Pharmacol. 2022 Apr 15;14(2):90-113. eCollection 2022.
6
The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.细胞外囊泡在介导肝细胞癌进展、转移及潜在治疗中的作用
Oncotarget. 2017 Jan 10;8(2):3683-3695. doi: 10.18632/oncotarget.12465.
7
Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma.外泌体在肝细胞癌免疫微环境中的作用
J Oncol. 2022 Jan 28;2022:2521025. doi: 10.1155/2022/2521025. eCollection 2022.
8
Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.肝细胞癌衍生的外泌体 miRNA-21 通过将肝星状细胞转化为癌相关成纤维细胞促进肿瘤进展。
J Exp Clin Cancer Res. 2018 Dec 27;37(1):324. doi: 10.1186/s13046-018-0965-2.
9
Exosome in Hepatocellular Carcinoma: an update.肝细胞癌中的外泌体:最新进展
J Cancer. 2021 Mar 5;12(9):2526-2536. doi: 10.7150/jca.54566. eCollection 2021.
10
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.酸性微环境上调早期肝细胞癌中细胞外体 miR-21 和 miR-10b,促进癌细胞增殖和转移。
Theranostics. 2019 Mar 16;9(7):1965-1979. doi: 10.7150/thno.30958. eCollection 2019.

引用本文的文献

1
Exosomes in Hepatocellular Carcinoma: A Comprehensive Review of Current Research and Future Directions.肝细胞癌中的外泌体:当前研究与未来方向的全面综述
J Cell Mol Med. 2025 Jul;29(14):e70723. doi: 10.1111/jcmm.70723.
2
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment.外泌体在实体癌进展中的作用及其在癌症治疗中的潜在疗法
Cancer Med. 2025 May;14(9):e70941. doi: 10.1002/cam4.70941.
3
The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review.

本文引用的文献

1
MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.MNX1-AS1,一种 c-Myc 诱导的长链非编码 RNA,通过调节 PKM2 核转位促进瓦博格效应。
J Exp Clin Cancer Res. 2022 Dec 7;41(1):337. doi: 10.1186/s13046-022-02547-3.
2
Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts.鳖甲煎丸通过下调癌相关成纤维细胞中的 PDGFRβ 信号抑制肝癌进展。
J Ethnopharmacol. 2023 Jan 30;301:115825. doi: 10.1016/j.jep.2022.115825. Epub 2022 Oct 12.
3
The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs.
中药衍生制剂在癌症免疫治疗中的应用:综述
Cancer Manag Res. 2025 Jan 11;17:23-34. doi: 10.2147/CMAR.S503071. eCollection 2025.
4
The role of exosomes in liver cancer: comprehensive insights from biological function to therapeutic applications.外泌体在肝癌中的作用:从生物学功能到治疗应用的全面见解。
Front Immunol. 2024 Oct 21;15:1473030. doi: 10.3389/fimmu.2024.1473030. eCollection 2024.
5
Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study.免疫细胞与肝细胞癌之间的因果关系:一项孟德尔随机化研究
J Cancer. 2024 Jun 3;15(13):4219-4231. doi: 10.7150/jca.96744. eCollection 2024.
6
Engineered exosomes and composite biomaterials for tissue regeneration.用于组织再生的工程化外泌体和复合生物材料。
Theranostics. 2024 Mar 3;14(5):2099-2126. doi: 10.7150/thno.93088. eCollection 2024.
7
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma.一种用于预测肝细胞癌经动脉化疗栓塞反应和预后的缺氧相关miRNA-mRNA特征
J Hepatocell Carcinoma. 2024 Mar 12;11:525-542. doi: 10.2147/JHC.S454698. eCollection 2024.
8
Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.基于坎那汀抑制肝癌细胞生长分子机制的靶基因的整合分析。
BMC Cancer. 2023 Nov 28;23(1):1161. doi: 10.1186/s12885-023-11594-8.
9
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers.源自肿瘤相关巨噬细胞的外泌体:在人类癌症中的生物发生、功能及治疗意义
Biomark Res. 2023 Nov 19;11(1):100. doi: 10.1186/s40364-023-00538-w.
中药使用者的特征和新发不可切除巨大肝癌(≥10cm)患者的死亡率:一项基于核心草药的回顾性队列研究
Int J Environ Res Public Health. 2022 Sep 30;19(19):12480. doi: 10.3390/ijerph191912480.
4
The Study of Exosomes-Encapsulated mPEG-PLGA Polymer Drug-Loaded Particles for Targeted Therapy of Liver Cancer.用于肝癌靶向治疗的外泌体包裹的聚乙二醇单甲醚-聚乳酸-羟基乙酸共聚物聚合物载药颗粒的研究
J Oncol. 2022 Sep 17;2022:4234116. doi: 10.1155/2022/4234116. eCollection 2022.
5
Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3.外泌体 miR-452-5p 通过靶向 TIMP3 诱导 M2 巨噬细胞极化促进肝癌进展。
J Immunol Res. 2022 Sep 16;2022:1032106. doi: 10.1155/2022/1032106. eCollection 2022.
6
Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases.外泌体介导的 Cas9 核糖核蛋白复合物传递用于肝脏疾病的组织特异性基因治疗。
Sci Adv. 2022 Sep 16;8(37):eabp9435. doi: 10.1126/sciadv.abp9435. Epub 2022 Sep 14.
7
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.miR-200c-3p、miR-222-5p 和 miR-512-3p 构成了索拉非尼治疗晚期肝细胞癌疗效的生物标志物特征。
Cells. 2022 Aug 28;11(17):2673. doi: 10.3390/cells11172673.
8
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights.索拉非尼耐药与肝细胞癌肿瘤微环境的关联:机制解析
Front Pharmacol. 2022 Aug 22;13:991052. doi: 10.3389/fphar.2022.991052. eCollection 2022.
9
Tumor-associated macrophages in liver cancer: From mechanisms to therapy.肝癌相关巨噬细胞:从机制到治疗。
Cancer Commun (Lond). 2022 Nov;42(11):1112-1140. doi: 10.1002/cac2.12345. Epub 2022 Sep 7.
10
Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.人自然杀伤细胞衍生的外泌体用于肝癌治疗的体内研究:皮下和原位动物模型。
Drug Deliv. 2022 Dec;29(1):2897-2911. doi: 10.1080/10717544.2022.2118898.